ABI1 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 4.847400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.178300E-03 |
Normal-vs-Stage2 |
2.64070000000061E-06 |
Normal-vs-Stage3 |
5.099600E-03 |
Normal-vs-Stage4 |
3.477600E-03 |
Stage1-vs-Stage2 |
1.641660E-03 |
Stage1-vs-Stage3 |
5.428200E-01 |
Stage1-vs-Stage4 |
3.456000E-01 |
Stage2-vs-Stage3 |
1.652390E-02 |
Stage2-vs-Stage4 |
6.223700E-02 |
Stage3-vs-Stage4 |
6.707000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.379500E-03 |
Normal-vs-AfricanAmerican |
4.057800E-02 |
Normal-vs-Asian |
8.041100E-03 |
Caucasian-vs-AfricanAmerican |
7.627200E-01 |
Caucasian-vs-Asian |
5.154000E-01 |
AfricanAmerican-vs-Asian |
8.603800E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.724500E-03 |
Normal-vs-Female |
6.631100E-04 |
Male-vs-Female |
9.909000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.213600E-02 |
Normal-vs-Age(41-60Yrs) |
4.792500E-04 |
Normal-vs-Age(61-80Yrs) |
2.4151999999944E-05 |
Normal-vs-Age(81-100Yrs) |
3.325000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.908230E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.396400E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.317000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.340600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.824200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.899400E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
5.489800E-01 |
Classical-VS-Follicular |
1.82970305573349E-11 |
Classical-VS-Other |
5.062800E-01 |
Classical-VS-Normal |
1.000010E-01 |
Tall-VS-Follicular |
2.07620000000075E-05 |
Tall-VS-Other |
3.985200E-01 |
Tall-VS-Normal |
5.364000E-01 |
Follicular-VS-Other |
1.345790E-01 |
Follicular-VS-Normal |
1.99329996952713E-09 |
Other-VS-Normal |
1.739020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.88170000003929E-06 |
Normal-vs-N1 |
1.090130E-02 |
N0-vs-N1 |
2.695800E-01 |
|
|